DYNORPHIN A-(1-13) ATTENUATES WITHDRAWAL IN MORPHINE-DEPENDENT RATS - EFFECT OF ROUTE OF ADMINISTRATION
DYNORPHIN A-(1-13) ATTENUATES WITHDRAWAL IN MORPHINE-DEPENDENT RATS - EFFECT OF ROUTE OF ADMINISTRATION
复制标题
DOI:
10.1016/0014-2999(88)90429-3
复制
发表时间:
1988-01-19
影响因子:
5
通讯作者:
LEE, NM
中科院分区:
文献类型:
--
作者:
GREEN, PG;LEE, NM
Rats were made tolerant to morphine by subcutaneous implantation of morphine alkaloid pellets. Three days after pellet implantation, withdrawal was induced by pellet removal and was assessed 6 h later. Immediately prior to withdrawal assessment, rats were injected with dynorphin A-(1-13) either i.th. (via a catheter), i.c.v. (via a cannula) or i.v. (via the tail vein). When administered i.th. in the dose range 1.25-5 nmol/rat, dynorphin A-(1-13) attenuated withdrawal over the 40 min observation period. Similarly, dynorphin A-(1-13) attenuated withdrawal over the 40 min observation period. Similarly, dynorphin A-(1-13) administered i.v. (37.5-150 nmol/kg) attenuated withdrawal, though only over the first 20 min following administration. Dynorphin A-(1-13) up to 10 nmol/rat had no effect on withdrawal scores. These data indicate that dynorphin acts at spinal sites to suppress withdrawal in morphine-dependent rats and may play a role in tolerance and dependence mechanisms.